Indraprastha Medical Corporation Limited (INDRAMEDCO.NS)
INR 500.05
(-0.28%)
INR 500.05
(-0.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.1 Billion INR | 20.3% |
| 2022 | 1.6 Billion INR | 34.18% |
| 2021 | 1.17 Billion INR | 212.54% |
| 2020 | 409.48 Million INR | -53.99% |
| 2019 | 870.78 Million INR | 5.72% |
| 2018 | 812.46 Million INR | 9.97% |
| 2017 | 721.99 Million INR | -7.8% |
| 2016 | 792.55 Million INR | -0.26% |
| 2015 | 814.96 Million INR | -9.22% |
| 2014 | 858.3 Million INR | -5.15% |
| 2013 | 918.48 Million INR | 15.14% |
| 2012 | 778.5 Million INR | 16.08% |
| 2011 | 657.87 Million INR | -4.95% |
| 2010 | -2.84 Billion INR | 2.21% |
| 2009 | 696.97 Million INR | 13.02% |
| 2008 | 616.68 Million INR | 27.76% |
| 2007 | 482.69 Million INR | 20.97% |
| 2006 | 402.32 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 671.2 Million INR | 35.46% |
| 2024 Q2 | 696.9 Million INR | -3.53% |
| 2023 Q3 | 515.7 Million INR | -5.43% |
| 2023 Q1 | 508.2 Million INR | 33.98% |
| 2023 FY | - INR | 20.3% |
| 2023 Q4 | 484.4 Million INR | -6.07% |
| 2023 Q2 | 545.3 Million INR | 7.3% |
| 2022 Q1 | 376.7 Million INR | 18.85% |
| 2022 FY | - INR | 34.18% |
| 2022 Q4 | 379.3 Million INR | -5.51% |
| 2022 Q3 | 401.4 Million INR | -10.78% |
| 2022 Q2 | 449.9 Million INR | 19.43% |
| 2021 Q4 | 316.94 Million INR | -0.65% |
| 2021 Q1 | 303.65 Million INR | 10.17% |
| 2021 FY | - INR | 212.54% |
| 2021 Q3 | 319.02 Million INR | 23.51% |
| 2021 Q2 | 258.28 Million INR | -14.94% |
| 2020 Q4 | 275.61 Million INR | 5.65% |
| 2020 Q1 | -248.95 Million INR | -278.97% |
| 2020 FY | - INR | -53.99% |
| 2020 Q3 | 260.87 Million INR | 172.45% |
| 2020 Q2 | 95.75 Million INR | 138.46% |
| 2019 Q1 | 229.68 Million INR | 45.0% |
| 2019 Q3 | 237.22 Million INR | 4.47% |
| 2019 Q4 | 139.1 Million INR | -41.36% |
| 2019 FY | - INR | 5.72% |
| 2019 Q2 | 227.06 Million INR | -1.14% |
| 2018 Q2 | 215.13 Million INR | 9.85% |
| 2018 Q1 | 195.85 Million INR | -1.53% |
| 2018 FY | - INR | 9.97% |
| 2018 Q4 | 158.39 Million INR | -22.5% |
| 2018 Q3 | 204.37 Million INR | -5.0% |
| 2017 Q4 | 198.88 Million INR | 7.56% |
| 2017 Q2 | 182.12 Million INR | 7.17% |
| 2017 Q1 | 169.94 Million INR | -5.21% |
| 2017 FY | - INR | -7.8% |
| 2017 Q3 | 184.9 Million INR | 1.53% |
| 2016 Q1 | 217.67 Million INR | 26.1% |
| 2016 FY | - INR | -0.26% |
| 2016 Q4 | 179.29 Million INR | -2.71% |
| 2016 Q3 | 184.28 Million INR | -16.97% |
| 2016 Q2 | 221.95 Million INR | 1.97% |
| 2015 Q4 | 172.61 Million INR | 9.25% |
| 2015 Q3 | 158 Million INR | -33.38% |
| 2015 FY | - INR | -9.22% |
| 2015 Q1 | 215.98 Million INR | 3.7% |
| 2015 Q2 | 237.16 Million INR | 9.8% |
| 2014 Q1 | 217.7 Million INR | 8.48% |
| 2014 Q4 | 208.27 Million INR | 7.33% |
| 2014 FY | - INR | -5.15% |
| 2014 Q3 | 194.04 Million INR | -18.56% |
| 2014 Q2 | 238.28 Million INR | 9.45% |
| 2013 Q2 | 258.26 Million INR | 8.78% |
| 2013 Q4 | 200.68 Million INR | -9.46% |
| 2013 FY | - INR | 15.14% |
| 2013 Q1 | 237.41 Million INR | 106.05% |
| 2013 Q3 | 221.65 Million INR | -14.17% |
| 2012 Q1 | 195.88 Million INR | 0.0% |
| 2012 FY | - INR | 16.08% |
| 2012 Q4 | -3.92 Billion INR | -307.01% |
| 2012 Q3 | 1.89 Billion INR | 870.35% |
| 2012 Q2 | 195.49 Million INR | -0.2% |
| 2011 FY | - INR | -4.95% |
| 2010 FY | - INR | 2.21% |
| 2009 FY | - INR | 13.02% |
| 2008 FY | - INR | 27.76% |
| 2007 FY | - INR | 20.97% |
| 2006 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 24.02 Billion INR | 91.247% |
| Artemis Medicare Services Limited | 1.24 Billion INR | -68.746% |
| Aster DM Healthcare Limited | 6.11 Billion INR | 65.621% |
| Fortis Healthcare Limited | 13.07 Billion INR | 83.919% |
| HealthCare Global Enterprises Limited | 3.5 Billion INR | 40.003% |
| Krishna Institute of Medical Sciences Limited | 6.61 Billion INR | 68.194% |
| Lotus Eye Hospital and Institute Limited | 79.42 Million INR | -2547.185% |
| Max Healthcare Institute Limited | 16.7 Billion INR | 87.412% |
| Max India Limited | -353.8 Million INR | 694.259% |
| Global Health Limited | 8.71 Billion INR | 75.884% |
| Narayana Hrudayalaya Limited | 12.42 Billion INR | 83.079% |
| Rainbow Children's Medicare Limited | 4.69 Billion INR | 55.211% |
| Shalby Limited | 1.98 Billion INR | -6.16% |